Spine Biologics Market Overview
Spine Biologics Market size is projected to reach $2,700 million by 2026, growing at a CAGR of 5.9% over 2021-2026. Spinal biologics is a kind of biological material that is used for healing the condition in the spinal. The use of spine biologics becomes an important component in any spinal fusion surgery. Spine biologics helps to provide a mechanism for the growth of bone. The biologics are commonly known as bone graft substitute that helps to improve the growth of new bone. Spine biologics provides a great option for the treatment of degenerative disc disease by reducing chronic back pain. Bone graft is segmented into autograft, allograft, and synthetic grafts which are considered as the most common adjuncts to many orthopedic procedures. Biologics therapies such as platelet-rich plasma represent the beginning of a paradigm shift in orthopedics that helps to avoid aggressive spinal surgery and reduce the need for long-term medications. The biologics in spinal fusion is a procedure that helps in improving the stability of the spine and also heals bone after a fracture. A growing issue in spine among population rising the adoption of spine biologics that helps to reduce various diseases such as degenerative disc diseases, spinal cord injuries, etc. and rising advancement in spine biologics procedure increases the treatment of spine disorder in a safe and effective way which is the major factor driving the growth of Spine Biologics Market. Furthermore, the growing elderly population increases the issues in the bone that rising the adoption of spine biologics process which is set to further enhance the overall market demand for Spine Biologics Market for the period 2021-2026.
Spine Biologics Market Report Coverage
The report: “Spine Biologics Market Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis of the following segments of the Spine Biologics Market.
By Product Type: Spinal Allografts, Demineralized Bone Matrix, Bone Graft Substitutes, Machined Bones Allograft, and Others
By Surgery Type: Minimally Invasive Spine Surgery, Open Spine Surgery, Lumbar Interbody Fusion, and Others
By End-User: Hospitals, Ambulatory Surgical Centers, and Others
By Geography: North America (U.S., Canada, Mexico), Europe (U.K, Germany, Italy, France, Spain, Russia, Rest of Europe), Asia Pacific (China, Australia, Japan, South Korea, India, Rest of Asia Pacific), South America (Brazil, Argentina, Others) and Rest of the World (Middle East, Africa)
- In 2020, North America dominated the Spine Biologics Market owing to growing advancement in the healthcare sector and rising adoption of a variety of advanced technologies for treating spinal injuries. Moreover, the rising number of people suffering from spinal disorders increases the adoption of spine biologics procedures which in turn enhancing the market growth.
- Growing issue in spine among population rising the adoption of spine biologics that helps to reduce various diseases such as degenerative disc diseases, spinal cord injuries, etc. and rising advancement in spine biologics procedure increases the treatment of spine disorder in a safe and effective way are improving the growth of the Spine Biologics Market.
- The prominent manufacturers operating in the market will be provided a detailed analysis of Strengths, Weaknesses, and Opportunities in the Spine Biologics Market report.
- High cost associated with spine biologics procedures which are set to create hurdles for the Spine Biologics Market.
Spine Biologics Market Size, By End-Use 2020 (%)
For More Details on This Report - Request for Sample
Spine Biologics Segment Analysis – By Product Type
The Spinal Biologics Market based on Product Type can be further distributed into Spinal Allografts, Demineralized Bone Matrix, Bone Graft Substitutes, Machined Bones Allograft, and Others. The Spinal allograft segment is the major segment generating revenue in 2020. The adoption of spinal allograft increases in the various healthcare sectors as it helps to provide immediate support in bone and also reduces the time in surgery that rising the adoption among surgeons. Moreover, it also helps to avoid the complications from a donor site that growing the demand for spinal allograft. The Bone Graft Substitutes segment is estimated to register the fastest CAGR of 6.1% for the period 2021-2026. Bone graft is the common process in various orthopedic procedures owing to its cost-effective properties that growing the adoption of bone graft among patients. Moreover, the rising adoption of bone grafting techniques growing the development of a minimally invasive bone graft that helps to provides superior bone regeneration outcomes with less pain, less swelling which further propelling the growth of the Spine Biologics Market.
Spine Biologics Segment Analysis – By End-User
The Spine Biologics Market based on End-User can be further segmented into Hospitals, Ambulatory Surgical Centers, and Others. The Hospitals segment registers for the highest Spine Biologics Market share in 2020. This is mainly owing to the rising number of facilities related to spinal surgeries growing the preference of hospitals among patients. Moreover, the rising availability of products which is needed for spinal surgeries in hospitals propelling the need of spinal biologics. The Ambulatory Surgical Centers segment is forecasted to register the fastest CAGR of 6.7% over 2021-2026. The rising number of people suffering from minimally invasive surgeries increases the need for ambulatory surgical centers as the availability of skilled surgeons is more that provides accurate treatment which in turn propelling the growth of the Spine Biologics Market.
Spine Biologics Segment Analysis – By Geography
North America dominated the Spine Biologics Market with a major share of 40% in 2020. This is owing to growing advancement in the healthcare sector and the rising adoption of a variety of advanced technologies for treating spinal injuries. Moreover, the rising number of people suffering from spinal disorders increases the adoption of spine biologics procedures which in turn enhancing the market growth. In the U.S., more than 1 million people are suffering from spinal cord injury according to the National Spinal Cord Injury Statistical Center in 2019 that furthers rising the adoption of spine biologics.
However, Asia Pacific is projected to be the growing market during the forecast period 2021-2026 owing to the growing population of elderly that needs the adoption of spine surgeries. In Asian countries, such as China, India, Japan, most people are suffering from obesity that rising the problems in spinal which further developing the adoption of the spine biologics market.
Spine Biologics Market Drivers
Growing issue in spine among population rising the adoption of spine biologics that helps to reduce various diseases such as degenerative disc diseases, spinal cord injuries and many more
Growing problems in spine area, is rising the adoption of spine biologics that helps to reduce various diseases such as degenerative disc disease, spinal cord injuries, and many more. According to the National Institute of Health, about 266 million people are suffering from degenerative disc diseases that is rising issues in the spine which is growing the adoption of spinal biologics procedures. Also, the incidence of spinal procedure surgery increases by 2% by 2019 that is rising the adoption of spinal biologics procedures. Moreover, spinal cord injury had a higher incidence of anxiety disorders, depressive disorders which in turn propelling the growth of the market over the period 2021-2026.
Rising advancement in spine biologics procedure increases the treatment of spine disorder in a safe and effective way
Rising improvement in technology growing the advancement in spine biologics procedures that helps in treating the spine disorder in a safe and effective manner. Moreover, the growing adoption of the S.M.A.R.T. bone grafting technique in various healthcare centers helps to reduce pain and swelling and can also treat the complex issues that boost the growth of the Spine Biologics Market over the period 2021-2026.
COVID-19 pandemic had greatly impacted the growth of the Spine Biologics Market. During pandemic, there were lockdowns and hospitals are occupied with the covid-19 patients and doctors are also busy caring for the COVID patients. This factor tends to decrease the treatment of spinal injuries which are negatively impacted the growth of the Spine Biologics Market.
Spine Biologics Market Challenges
High Cost Associated with Spinal Biologics
The factors that are set to impede the growth of the Spine Biologics Market are the rising cost of treatment with spinal biologics procedures. Technological advancement increases the use of a wide variety of technology for spinal surgeries in order to provide easy procedures that raising the cost of spinal biologics procedures. Recently, in hospitals, the surgeon's fees are increased by 15% that tends to raise the cost of spinal surgery procedures. So, many patients are not able to afford the high cost of procedures that reduce the adoption of spinal biologics procedures which is set to challenging the market of Spine Biologics.
Spine Biologics Landscape
Product launches, acquisitions, collaboration, joint ventures, and geographical expansions are key strategies adopted by players in the Spine Biologics Market. Spine Biologics top 10 companies are
1.Zimmer Biomet Holdings inc
2. Nuvasive Inc
3. Depuy Synthes
4. Orthofix International N.V
5. K2M, Inc
6. Exactech, Inc
8. Arthrex, Inc.
9. Wright Medical Technology
10. Aziyo Biologics
- In 2021, Biogennix launched advanced bone grafting solution that helps to increase direct contact with bone when implanted and reduces the pain.
Report Code: HCR 66188
Report Code: HCR 43262
For more Lifesciences and Healthcare Market reports, please click here
1. Spine Biologics Market Overview
1.1 Definitions and Scope
2. Spine Biologics Market Executive Summary
2.1 Market Size and Key Trends
2.2 Key trends by Product Type
2.3 Key trends by Surgery Type
2.4 Key trends by End-Use
2.5 Key trends by Geography
3. Spine Biologics Market Landscape
3.1 Market Share Analysis- Key Companies
3.2 Product Benchmarking- Key Companies
3.3 Financial Analysis - Key Companies
3.4 Patent Analysis
3.5 Pricing Analysis
4. Spine Biologics Market- Startup companies Scenario Premium Premium
4.1 Key startup company Analysis by
4.1.3 Application Analysis
4.1.4 Venture Capital and Funding Scenario
5. Spine Biologics Market- Industry Market Entry Scenario Premium Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case Studies of successful ventures
6. Spine Biologics Market Forces
6.1 Market Drivers
6.2 Market Constraints/Challenges
6.3 Porters Five Force Model
6.3.1 Bargaining Power of Suppliers
6.3.2 Bargaining Powers of Customers
6.3.3 Threat of New Entrants
6.3.4 Rivalry Among Existing Players
6.3.5 Threat of Substitutes
7. Spine Biologics Market Strategic Analysis
7.1 Value Chain Analysis
7.2 Opportunities Analysis
7.3 Market Life Cycle
8. Spine Biologics Market– By Product Type (Market Size -$Million/$Billion)
8.1 Spinal Allografts
8.2 Demineralized Bone Matrix
8.3 Bone Graft Substitutes
8.4 Machined Bone Allograft
9. Spine Biologics Market– By Surgery Type (Market Size -$Million/$Billion)
9.1 Minimally Invasive Spine Surgery
9.2 Open Spine Surgery
9.3 Lumbar Interbody Fusion
10. Spine Biologics Market– By End-Use (Market Size -$Million/$Billion)
10.2 Ambulatory Surgical Centers
11. Spine Biologics Market- By Geography (Market Size -$Million/$Billion)
11.1 North America
11.2.7 Rest of Europe
11.3.4 South KoreaText Box: 06
11.3.6 Rest of Asia-Pacific
11.4 South America
11.5 Rest of the World
11.5.1 Middle East
12. Spine Biologics Market Entropy
13. Spine Biologics Market- Industry / Segment Competition landscape Premium Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Key companies
13.1.2 Market Share by Region- Key companies
13.1.3 Market Share at Global Level- Key companies
13.1.4 Competition Matrix
13.1.5 Best Practices for Companies
14. Spine Biologics Market- Key Company List by Country Premium Premium
15. Spine Biologics Market Company Analysis
15.1 Company Revenue, Products, M&A, Developments
15.2 Company 1
15.3 Company 2
15.4 Company 3
15.5 Company 4
15.6 Company 5
15.7 Company 6
15.8 Company 7
15.9 Company 8
15.10 Company 9
15.11 Company 10
"*Financials for private companies would be provided on a best efforts basis”.